Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 9 studies | 29% ± 10% | |
astrocyte | 8 studies | 22% ± 7% | |
glutamatergic neuron | 6 studies | 37% ± 20% | |
neuron | 4 studies | 24% ± 3% | |
GABAergic neuron | 4 studies | 38% ± 15% | |
oligodendrocyte precursor cell | 4 studies | 22% ± 3% | |
endothelial cell | 3 studies | 35% ± 4% | |
retinal ganglion cell | 3 studies | 41% ± 17% | |
epithelial cell | 3 studies | 32% ± 8% | |
secretory cell | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 26% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 9471.62 | 2580 / 2642 | 100% | 140.46 | 702 / 705 |
uterus | 99% | 6100.45 | 169 / 170 | 97% | 119.16 | 446 / 459 |
prostate | 100% | 12762.27 | 245 / 245 | 96% | 44.02 | 484 / 502 |
esophagus | 100% | 8862.90 | 1443 / 1445 | 91% | 190.59 | 166 / 183 |
ovary | 100% | 7831.23 | 180 / 180 | 90% | 51.75 | 387 / 430 |
adrenal gland | 100% | 13437.97 | 258 / 258 | 88% | 63.77 | 203 / 230 |
bladder | 100% | 6288.24 | 21 / 21 | 86% | 93.36 | 435 / 504 |
breast | 95% | 5542.49 | 435 / 459 | 89% | 48.62 | 999 / 1118 |
lung | 93% | 3951.38 | 539 / 578 | 84% | 120.80 | 975 / 1155 |
kidney | 89% | 5189.17 | 79 / 89 | 81% | 34.51 | 730 / 901 |
skin | 100% | 16511.35 | 1809 / 1809 | 68% | 53.56 | 319 / 472 |
thymus | 88% | 2904.66 | 574 / 653 | 76% | 34.94 | 462 / 605 |
pancreas | 60% | 1997.49 | 197 / 328 | 94% | 62.82 | 168 / 178 |
liver | 87% | 3177.13 | 197 / 226 | 63% | 29.11 | 256 / 406 |
intestine | 89% | 4734.98 | 855 / 966 | 59% | 23.65 | 313 / 527 |
stomach | 74% | 3068.97 | 264 / 359 | 66% | 30.44 | 188 / 286 |
muscle | 100% | 13494.98 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 60.46 | 1 / 1 |
blood vessel | 100% | 9898.34 | 1329 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 175.25 | 44 / 45 |
heart | 98% | 12930.73 | 840 / 861 | 0% | 0 | 0 / 0 |
adipose | 96% | 6279.43 | 1152 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 52.11 | 76 / 80 |
spleen | 68% | 2380.32 | 164 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 2.16 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0014037 | Biological process | Schwann cell differentiation |
GO_2001016 | Biological process | positive regulation of skeletal muscle cell differentiation |
GO_0032288 | Biological process | myelin assembly |
GO_0030200 | Biological process | heparan sulfate proteoglycan catabolic process |
GO_1905475 | Biological process | regulation of protein localization to membrane |
GO_0016477 | Biological process | cell migration |
GO_0040037 | Biological process | negative regulation of fibroblast growth factor receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0005796 | Cellular component | Golgi lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0031012 | Cellular component | extracellular matrix |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0098552 | Cellular component | side of membrane |
GO_0005768 | Cellular component | endosome |
GO_0043236 | Molecular function | laminin binding |
GO_0005507 | Molecular function | copper ion binding |
GO_0017134 | Molecular function | fibroblast growth factor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GPC1 |
Protein name | Glypican-1 Glypican-1 [Cleaved into: Secreted glypican-1] |
Synonyms | |
Description | FUNCTION: Cell surface proteoglycan that bears heparan sulfate. Binds, via the heparan sulfate side chains, alpha-4 (V) collagen and participates in Schwann cell myelination (By similarity). May act as a catalyst in increasing the rate of conversion of prion protein PRPN(C) to PRNP(Sc) via associating (via the heparan sulfate side chains) with both forms of PRPN, targeting them to lipid rafts and facilitating their interaction. Required for proper skeletal muscle differentiation by sequestering FGF2 in lipid rafts preventing its binding to receptors (FGFRs) and inhibiting the FGF-mediated signaling. . FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan. . |
Accessions | C9J4Y6 ENST00000426280.3 ENST00000264039.7 [P35052-1] H7BZL4 P35052 ENST00000455111.1 ENST00000425056.5 ENST00000427506.5 H7C410 H7BZE9 H7C024 ENST00000420138.5 |